Harpoon Therapeutics Appoints Omer Siddiqui as VP Development Operations and Project Management

NEXT STORY
TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science Journal
PREV STORY
Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients

author_avatar
NASDAQ Market News

Polyphor Announces Financial Results for the Full-Year 2020

author_avatar
NASDAQ Market News

Novartis im 3. Qu. mit solider Performance: operatives Kernergebnis steigt um 11%, Nettoumsatz auf Vorjahresniveau, starke Pipeline-Fortschritte; Jahresprognose für operatives Kernergebnis angehoben

author_avatar
NASDAQ Market News